Total operating loss was USD 3.9 million, against a loss of USD 0.1 million. AdjustedOperating Incomewas USD 0.3 million, against USD 4.2 million, and the adjusted operating ratio was 99.8%, against 96.3%. The company attributed the ratio to elevated costInflationand fuelSurchargeunder-recovery that more than …
Total cost of services was USD 56.7 million, against USD 51.8 million, including salaries and benefits of USD 41.9 million, against USD 37.8 million. GrossMarginwas USD 8.2 million, against USD 9.4 million. General and administrative expenses were USD 7.9 million, against USD 7.3 million, …
Revenue consisted of USD 671 thousand of collaboration revenue and USD 1,443 thousand of collaboration revenue from a related party. There was no revenue in the third quarter of 2025. For the nine months, total revenue was USD 2.3 million.
Total production averaged 5,850 barrels of oil equivalent per day in the third quarter, against 1,471 in the same quarter of 2025.Natural Gasproduction was 5,106 thousand cubic feet per day, against 1,395, and natural gas liquids production was 783 barrels per day, against 185.
Net revenues decreased USD 1.0 million, or 5%, to USD 21.2 million, against USD 22.3 million a year earlier. The filing attributes the change primarily to fluctuations within the firearm and non-firearm product categories, offset in part by the start of service revenues. Firearm …
Research and development expenses were USD 17.9 million, in line with the same quarter of 2025. The filing states that program expenses, including clinical trial and third-party contracting costs, were USD 10.0 million, against USD 2.0 million, and that the USD 8.0 million increase …
Its product candidates are PMN310, a monoclonal antibody for Alzheimer's disease, PMN267 for amyotrophic lateral sclerosis and PMN442 for synucleinopathies such as dementia with Lewy bodies and Parkinson's disease.
The company described the first-half revenue and Adjusted EBITDA as records. Kit Gray, President and Co-Founder, said the company is focused on building long-term value and driving sustainable growth, citing audience growth, an expanding content portfolio and progress across itsAdvertisingand subscription businesses.
The filing shows collaboration revenue from a related party of USD 4,213 thousand for the quarter, against USD 1,179 thousand a year earlier.
Revenue was USD 174 thousand for the three months ended September 30, 2026, against USD 217 thousand a year earlier. The filing states it relates to leasing revenue.Research and Developmentexpenses were USD 40.8 million, against USD 26.8 million. The filing attributes the USD 14.0 …